The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III
Recruiting
Phase 3
Interventional Study
Lung Cancer
Gastric Cancer
Esophageal Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Ottawa Hospital Research Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Despite enormous advances in thoracic surgery and oncology, two critical issues concern patients undergoing curative-intent surgery for lung, gastric and esophageal cancer: first, a majority (\~60%) of patients experience minor and major adverse events occurring during and in the days following surgery; second, patients worry about the significant risk of cancer recurrence and mortality months to …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
• Adults eligible for complete resection of lung, gastric or esophageal cancer
Exclusion criteria
* Small cell, carcinoid, or gastrointestinal stromal (GIST) tumours
* Any wedge resections of lung cancer
* History of cancer with active treatment in the last 3 years (not includi…
Contacts